Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.88 USD | -4.33% | -6.60% | -41.57% |
Sales 2024 * | 238M 303M | Sales 2025 * | 259M 330M | Capitalization | 1.64B 2.09B |
---|---|---|---|---|---|
Net income 2024 * | -80M -102M | Net income 2025 * | -95M -121M | EV / Sales 2024 * | 5.78 x |
Net cash position 2024 * | 263M 335M | Net cash position 2025 * | 214M 272M | EV / Sales 2025 * | 5.49 x |
P/E ratio 2024 * |
-21.6
x | P/E ratio 2025 * |
-17.5
x | Employees | 497 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.66% |
Latest transcript on Immunocore Holdings plc
1 day | -4.34% | ||
1 week | -6.60% | ||
Current month | -18.50% | ||
1 month | -32.28% | ||
3 months | -34.51% | ||
6 months | -31.76% | ||
Current year | -41.57% |
Managers | Title | Age | Since |
---|---|---|---|
Bahija Jallal
CEO | Chief Executive Officer | 62 | 18-12-31 |
Brian DiDonato
DFI | Director of Finance/CFO | 57 | 20-03-31 |
John Trainer
COO | Chief Operating Officer | 50 | 23-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Perez
BRD | Director/Board Member | 59 | 19-08-31 |
John Bell
CHM | Chairman | 71 | 15-02-28 |
Bahija Jallal
CEO | Chief Executive Officer | 62 | 18-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 1,184 M€ | +9.77% | - | |
0.18% | 0 M€ | 0.00% | - | |
0.14% | 4 M€ | +15.79% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 39.93 | -4.20% | 454 630 |
24-06-07 | 41.68 | -2.37% | 778,754 |
24-06-06 | 42.69 | -0.84% | 455,665 |
24-06-05 | 43.05 | -0.60% | 758,245 |
24-06-04 | 43.31 | +1.33% | 1,753,046 |
Delayed Quote Nasdaq, June 10, 2024 at 01:27 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.57% | 2.08B | |
+47.38% | 765B | |
-6.61% | 354B | |
+19.67% | 331B | |
+9.11% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.10% | 164B | |
-2.69% | 162B |
- Stock Market
- Equities
- IMCR Stock